Understanding the Priority in Hemolytic-Uremic Syndrome (HUS)
The clinical presentation of this 5-year-old child—oliguria, hypertension, severe anemia (hemoglobin
6.2 g/dL), thrombocytopenia (platelet count
45,000/mm³), and elevated BUN and creatinine—is classic for
Shiga toxin-producing Escherichia coli hemolytic uremic syndrome (STEC-HUS). While HUS is widely recognized as a leading cause of acute kidney injury in children, the systemic nature of the disease means the toxin-mediated endothelial injury is not confined to the renal vasculature
[1]. The highest priority nursing intervention must address the most life-threatening potential complication that requires immediate recognition and intervention.
Why Neurological Monitoring is the Priority
The correct answer is to monitor for signs of neurological complications and seizures. The rationale is rooted in the pathophysiology of STEC-HUS. Shiga toxins circulate and bind to globotriaosylceramide (Gb3) receptors, which are highly expressed not only on renal endothelial cells but also on the microvasculature of the brain. This leads to
thrombotic microangiopathy in the central nervous system (CNS), manifesting as a spectrum of extrarenal complications. Neurological involvement is one of the most serious and common extrarenal manifestations of STEC-HUS, and it can present acutely with altered mental status, seizures, or focal neurological deficits
[1]. Because these CNS events can deteriorate rapidly, leading to irreversible brain injury or death, continuous and vigilant neurological assessment is the nurse's highest priority for early detection and timely escalation of care.
Analyzing the Incorrect Options
Option 1: Encourage increased fluid intake to prevent dehydration
This intervention is contraindicated. The child is in acute kidney injury, evidenced by
oliguria and elevated BUN/creatinine. The kidneys are unable to effectively excrete fluid. Encouraging fluid intake would worsen fluid overload, exacerbating hypertension and increasing the risk of pulmonary edema and heart failure. Management in the oliguric phase typically involves strict fluid restriction, not encouragement of intake.
Option 2: Administer aspirin for fever and discomfort management
This is dangerous. The child has severe thrombocytopenia with a platelet count of
45,000/mm³. Aspirin impairs platelet function through irreversible cyclooxygenase inhibition, which would compound the existing bleeding risk. Antipyretics with minimal effects on platelet function, such as acetaminophen, would be the preferred agent if needed, but pain and fever management do not supersede the priority of detecting life-threatening CNS complications.
Option 3: Provide a high-protein diet to support kidney function
This intervention is not appropriate during the acute phase of HUS. In the setting of acute kidney injury with elevated BUN and creatinine, protein intake is typically restricted, not increased. A high-protein diet would increase the production of nitrogenous waste products, which the injured kidneys cannot clear, further elevating the BUN and worsening uremia. The immediate nutritional focus is on providing adequate calories while restricting protein, fluids, and electrolytes like sodium and potassium.
Connecting to the Evidence
The study by Alconcher et al. explicitly highlights that STEC-HUS is a systemic disease where extrarenal complications, particularly neurological ones, are a major concern and can lead to long-term sequelae
[1]. The research underscores the need for clinicians to look "beyond the kidney" during the acute phase. Furthermore, the study by Jarosz-Wójcik et al. reinforces the assessment of complications and outcomes in pediatric HUS, confirming that the disease course involves multiple organ systems and requires comprehensive monitoring for complications beyond the renal system . These findings directly support prioritizing the detection of neurological involvement, as it represents an immediate, life-threatening extrarenal manifestation that demands constant nursing vigilance.
References (research sources)
- [1]
Beyond the kidney: prevalence of extrarenal complications and their long-term sequelae in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.Research articleAlconcher LF, Lucarelli LI, Bronfen S, Villarreal F. (2026) · DOI: 10.1007/s00467-026-07376-6